With the FDA approval of Gilead's seladelpar, there have now been two in a matter of weeks. The US agency has cleared seladelpar under the Livdelzi brand name as a second-line therapy for PBC in ...

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term ...

The most recent trading session ended with Gilead Sciences (GILD) standing at $91.41, reflecting a -0.51% shift from the previouse trading day's closing. The stock's performance was behind the S&P ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for ...

After Donald Trump suggested he might take over Greenland by force, the consensus among the island’s population appears to be bewilderment and anxiety. By Jeffrey Gettleman and Maya Tekeli ...

That's all for our live coverage of the war in Ukraine. We'll be back tomorrow with more updates. Here's a rundown of the key lines from today: Ukraine's military has said it was responsible for a ...

After hours: 7:54:57 p.m. EST Loading Chart for GILD ...

Thomasville, NC, Oct. 31--Unilin Flooring N.V., has signed an agreement with Homanit Inc. to acquire Homanit's MDF (Medium Density Fiberboard) plant in Mount Gilead, NC. Homanit is the sister firm ...